ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)

ClinicalTrials.gov ID: NCT00493974

Public ClinicalTrials.gov record NCT00493974. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 12:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Antileukotriene Therapy for COPD Exacerbations

Study identification

NCT ID
NCT00493974
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of Minnesota
Other
Enrollment
119 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Zileuton Drug

Drug

Eligibility (public fields only)

Age range
45 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Nov 17, 2019

2007 – 2008

United States locations

U.S. sites
18
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
University of Alabama Lung Health Center Birmingham Alabama 35249
Veteran's Administration Medical Center Birmingham Alabama 35294
LA BioMed at Harbor, University of California Los Angeles California 90502
University of California San Francisco-Airway Clinical Research Center San Francisco California 94143
Denver Health Medical Center Denver Colorado 80204
National Jewish Medical and Research Center Denver Colorado 80206
Veteran's Administration Medical Center Denver Colorado 80220
University of Maryland Hospital Baltimore Maryland 21201
Fallon Clinic Boston Massachusetts 01605
Brigham and Women's Hospital Boston Massachusetts 02115
Veteran's Administration Medical Center Boston Massachusetts 02132
Veteran's Administration Medical Center Ann Arbor Michigan 48105
University of Michigan Medical Center Ann Arbor Michigan 48109
Veteran's Administration Medical Center Minneapolis Minnesota 55417
HealthPartners Research Foundation Minneapolis Minnesota 55440
Mayo Clinic Rochester Minnesota 55905
Temple University Lung Center Philadelphia Pennsylvania 19140
University of Pittsburgh Emphysema Research Center Pittsburgh Pennsylvania 15213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00493974, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2019 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00493974 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →